News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
February, 2025
February 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
2425262728  
Beau Bosko Toskich: A multidisciplinary review of combination Y90 and Immunotherapy for HCC
Beau Bosko Toskich/X
Nov 24, 2024, 13:47

Beau Bosko Toskich: A multidisciplinary review of combination Y90 and Immunotherapy for HCC

Beau Bosko Toskich, Interventional Radiologist at Mayo Clinic, shared a post on X:

“A multidisciplinary and comprehensive review of combination Y90 and Immunotherapy for HCC.

ROWAN and EMERALD Y90 clinical trials are investigating these therapies with current practice.”

Beau Bosko Toskich

Beau Bosko Toskich cancer EMERALD Y90 immunotherapy Mayo Clinic OncoDaily Oncology Rowan
Special Coverage
Blog
Feb 26, 2025, 15:12
The powerful synergy between MiNK’s allo-iNKT cells and chemotherapy in Gastric Cancer - MiNK Therapeutics
Opinion
Feb 26, 2025, 15:07
Debunking Cancer Prevention: The Essential Role of Risk Reduction - Sami Mansfield
Blog
Feb 26, 2025, 14:04
Sami (Papacek) Mansfield: The discussion of myokines in cancer is exciting
Career
Feb 26, 2025, 13:39
Dan Theodorescu has been appointed as the Director of University of Arizona Cancer Center
Science
Feb 26, 2025, 13:37
Olivier Elemento: How do early lung tumors evolve?
Drugs
Feb 26, 2025, 13:29
FDA approves Vimseltinib(Romvimza) for symptomatic Tenosynovial Giant Cell Tumor (TGCT)
Blog
Feb 26, 2025, 12:12
David Korn: Honoring the legacy of Professor Giovanni Scambia
Science
Feb 26, 2025, 12:06
Emad Shash: The role of adjuvant radiotherapy in postmenopausal women with early-stage ER+ breast cancer
Blog
Feb 26, 2025, 11:56
The FDA has approved vimseltinib by Deciphera Pharmaceuticals for TGCT - The Babak Lab
Blog
Feb 26, 2025, 11:46
Karan Cushman: Can AI Help CURE Cancer?
Blog
Feb 26, 2025, 11:46
A Milestone for Children's Palliative Care in Ghana - World Child Cancer
Blog
Feb 26, 2025, 11:44
Michael Chuong: The second special edition for SBRT/SRS in Cancers